Target Healthcare REIT (LON:THRL – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 113 and last traded at GBX 110.60, with a volume of 34288 shares changing hands. The stock had previously closed at GBX 110.76.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 101 price target on shares of Target Healthcare REIT in a research report on Wednesday, May 6th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of GBX 101.
Read Our Latest Research Report on Target Healthcare REIT
Target Healthcare REIT Stock Up 0.0%
Target Healthcare REIT Company Profile
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Read More
- Five stocks we like better than Target Healthcare REIT
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
